| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.37B | 26.20B | 24.81B | 22.88B | 21.87B | 21.00B |
| Gross Profit | 6.02B | 11.52B | 12.27B | 11.03B | 10.33B | 10.44B |
| EBITDA | 1.92B | 6.68B | 5.59B | 4.50B | 3.68B | 3.72B |
| Net Income | 3.32B | 5.05B | 4.26B | 3.55B | 3.08B | 2.92B |
Balance Sheet | ||||||
| Total Assets | 831.41B | 815.31B | 689.96B | 607.99B | 529.61B | 522.25B |
| Cash, Cash Equivalents and Short-Term Investments | 34.91B | 64.78B | 67.18B | 46.98B | 38.33B | 60.47B |
| Total Debt | 260.97B | 253.26B | 99.75B | 89.56B | 75.13B | 92.20B |
| Total Liabilities | 787.88B | 773.43B | 645.06B | 568.05B | 493.02B | 488.92B |
| Stockholders Equity | 42.41B | 40.79B | 43.93B | 39.06B | 35.82B | 32.64B |
Cash Flow | ||||||
| Free Cash Flow | 28.39B | 6.83B | 22.58B | 9.73B | -2.17B | 2.38B |
| Operating Cash Flow | 28.48B | 7.20B | 22.95B | 10.14B | -1.67B | 3.01B |
| Investing Cash Flow | -41.81B | -34.55B | -13.28B | -17.05B | -10.27B | -4.45B |
| Financing Cash Flow | -6.85B | 21.56B | 5.83B | 10.99B | -19.45B | 15.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$39.38B | 3.55 | 9.70% | 5.69% | 11.27% | 12.75% | |
72 Outperform | HK$70.42B | 1.37 | 9.94% | 7.06% | -1.22% | 9.13% | |
71 Outperform | HK$87.24B | 4.35 | 9.19% | 5.16% | -1.33% | 7.09% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$33.68B | 3.69 | 12.90% | 4.45% | ― | ― | |
56 Neutral | HK$24.87B | 4.55 | 6.51% | 7.99% | -8.83% | -16.92% | |
50 Neutral | HK$13.90B | 5.08 | 0.67% | ― | -6.29% | -6.68% |